| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
Briciclib
|
865783-99-9 |
BRICICLIB
|
|
C19H23O10PS |
474.418681 | |
|
CYM 5442 Hydrochloride
|
1094042-01-9 |
CYM5442
|
CYM 5442;CYM-5442
|
C23H27N3O4 |
409.47818 | |
|
Isocyclosporin A
|
59865-16-6 |
异构环孢菌素A
|
环孢素杂质9;环孢菌素A异构体;异构环孢菌素A;异环孢菌素A;异构环孢素杂质A;环孢素A异构体;CS-2544
|
C62H111N11O12 |
1202.61124 | |
|
FPH2
|
957485-64-2 |
FPH2(BRD-9424)
|
4-[[[(5-氯-2-甲氧基苯基)氨基]硫代甲酰]氨基]-1-乙基-1H-吡唑-3-甲酰胺;FPH2(BRD-9424)
|
C14H16ClN5O2S |
353.82714 | |
|
Sapacitabine
|
151823-14-2 |
N-[1-[(2R,3S,4S,5R)-3-氰基-4-羟基-5-(羟甲基)氧杂环戊-2-基]-2-氧代嘧啶-4-基]十六酰胺
|
N-[1-[(2R,3S,4S,5R)-3-氰基-4-羟基-5-(羟甲基)氧杂环戊-2-基]-2-氧代嘧啶-4-基]十六酰胺;CYC 682;CYC-682;CS-682;CS682;CS 682;10G,50G,100G,2KG
|
C26H42N4O5 |
490.63548 | |
|
Fevipiprant
|
872365-14-5 |
FEVIPIPRANT
|
非维匹仑;非韦匹仑;CS-2449;NVP-QAW039; QAW039;QAW039;QAW-039;QAW 039;FEVIPIPRANT;NVP-QAW039;QAW039
|
C19H17F3N2O4S |
426.4094896 | |
|
TUG 891
|
1374516-07-0 |
TUG 891
|
TUG 891;TUG-891;CS-2448
|
C23H21FO3 |
364.41 | |
|
MK-6892
|
917910-45-3 |
MK 6892
|
MK 6892;MK6892;CS-2425
|
MK |
39.0983 | |
|
MX69
|
1005264-47-0 |
NULL
|
MX-69;MX69 (MX 69
|
C27H26N2O4S |
474.57134 | |
|
IWP 4
|
686772-17-8 |
CS-2394
|
2-((3-(2-甲氧基苯基(-4-氧代-3,4,6,7-四氢噻吩并[3,2-D]嘧啶-2-基(硫代(-N-(6-甲基苯并[D]噻唑-2-基(乙酰胺;IWP4;IWP 4;CS-2394
|
C23H20N4O3S3 |
496.6249 | |
|
Alvespimycin
|
467214-20-6 |
阿螺旋霉素
|
17-DMAG;KOS-1022;NSC-707545;阿螺旋霉素(17-DMAG);CS-2382;17-[2-(二甲基氨基)乙基氨基]-17-去甲基格尔德霉素;阿螺旋霉素;17-[2-(二甲基氨基)乙基氨基]-18-去甲氧基格尔德霉素
|
C32H48N4O8 |
616.74552 | |
|
PD 150606
|
179528-45-1 |
PD 150606
|
PD150606;PD-150606;PD 150606;CS-2366;(Z)-3-(4-IODOPHENYL)-2-SULFANYLPROP-2-ENOIC ACID
|
C9H7O2SI |
306.11968 | |
|
N-(2-Aminoethyl)-5-(3-fluorophenyl)thiazole-4-carboxamide
|
127500-84-9 |
CS-2324
|
RO 41-1049 HCL MAO-A INHIBITOR;RO 41-1049 HYDROCHLORIDE MAO-A INHIBITOR;Ro 41-1049;N-(2-Aminoethyl)-5-(3-fluorophenyl)-4-thiazolecarboxamide;N-(2-Aminoethyl)-5-(3-fluorophenyl)thiazole-4-carboxamide;RO41-1049HCL
|
C12H12N3OFS |
265.30658 | |
|
BTZ043
|
1161233-85-7 |
2-[(2S)-2-甲基-1,4-二氧杂-8-氮杂螺[4.5]癸烷-8-基]-8-硝基-6-三氟甲基-4H-1,3-苯并噻嗪-4-酮
|
BTZ043 (BTZ-043;2-[(3S)-3-methyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl]-8-nitro-6-(trifluoromethyl)-1,3-benzothiazin-4-one;BTZ043;BTZ043 raceMate;2-[(2S)-2-Methyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl]-8-nitro-6-trifluoromethyl-4H-1,3-benzothiazin-4-one;BTZ 10526043;PBTZ 169
|
C17H16F3N3O5S |
431.3894 | |
|
2-Methoxy-N-[(2E)-3-[4-[[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinazolinyl]-2-propen-1-yl]acetamide
|
383432-38-0 |
2-甲氧基-N-[(2E)-3-[4-[[3-甲基-4-[(6-甲基-3-吡啶基)氧基]苯基]氨基]-6-喹唑啉基]-2-丙烯-1-基]乙酰胺
|
CS-2306;CP-724;714;CP724;714;CP 724714;CP 724;714;CP724714;CP-724714;CP 724714;CP724714;CP-724714 (E-DOUBLE BOND);2-甲氧基-N-[(2E)-3-[4-[[3-甲基-4-[(6-甲基-3-吡啶基)氧基]苯基]氨基]-6-喹唑啉基]-2-丙烯-1-基]乙酰胺
|
C27H27N5O3.CH4O3S |
565.64064 | |
|
HTH-01-015
|
1613724-42-7 |
N/A
|
5,13-二氢-4,13-三甲基-2-[[1-(4-哌啶基)-1H-吡唑-4-基]氨基]-6H-萘并[2,3-E]嘧啶并[5,4-B][1,4]二氮杂卓-6-酮;CS-2296
|
C26H28N8O |
468.55352 | |
|
Pristinamycin
|
270076-60-3 |
普那霉素
|
普那霉;CS-2276;CS-2278
|
C45H54N8O10 |
||
|
FRAX1036
|
1432908-05-8 |
FRAX1036
|
FRAX-1036;FRAX 1036;CS-2271
|
C28H32ClN7O |
518.05298 | |
|
SHP099 Hydrochloride
|
1801747-11-4 |
SHP-099盐酸盐
|
SHP-099盐酸盐;SHP099;SHP 099;SHP-099;CS-2267
|
C16H20Cl3N5 |
388.7225 | 200-258-5 |
|
GDC-0152
|
873652-48-3 |
GDC-0152
|
GDC-0152; GDC0152; GDC 0152.;GDC0152;GDC 0152.;(S)-1-((S)-2-环己基-2-((S)-2-(甲基氨基)丙酰胺基)乙酰基)-N-(4-苯基-1,2,3-噻二唑-5-基)吡咯烷-2-甲酰胺
|
C25H34N6O3S |
498.6486 |
药智官方微信
药智官方微博
